Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma

NCT01468818 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

18

Enrollment

NIH

Sponsor class

Stopped Study was closed prematurely due to slow and insufficient accrual.

Conditions

Metastatic Melanoma
Skin Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Young Tumor Infiltrating Lymphocytes (TIL)

Sponsor

National Cancer Institute (NCI)